Medical Device News Magazine

SOTA’s Dental Imaging Software Gets Pearl’s AI Pathology Detection Capabilities

Pearl and SOTA have partnered to offer native support for Pearl’s industry-leading, FDA-cleared radiologic AI solution Second Opinion® within the SOTA Cloud® software platform. SOTA Cloud® will be the first dental imaging software in the United States to offer a fully-integrated clinical AI feature set.

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Pearl, the global leader in dental AI solutions, and SOTA Imaging, the leading manufacturer of dental imaging hardware and software, announced today a partnership to integrate Pearl’s FDA-cleared Second Opinion® real-time clinical pathology detection artificial intelligence (AI) solution with SOTA’s popular SOTA Cloud® dental imaging software.

Native support for Pearl’s chairside AI within SOTA’s cloud-based imaging interface means that, for the first time, dentists in the United States can conveniently capture, display, and perform AI-assisted clinical evaluation of dental radiographs within a single software platform.

“Together with SOTA, we are pushing the envelope of dental imaging further toward a fully AI-powered dental future,” said Ophir Tanz, Pearl’s founder and CEO. “AI will be a basic utility in dentistry and we see obvious advantages to making that utility an integral feature of the tools that dentists are already using. Through this partnership, dentists using SOTA Cloud® can seamlessly access Pearl’s AI capabilities to obtain better, more consistent insights from patient imagery and present cases to patients more effectively –– leading to better outcomes, a higher standard of care and more productive patient communication.”

Pearl’s Second Opinion® is a clinical AI system cleared for use as a patient-facing radiologic aid to dentists in over 90 countries. With native Second Opinion® integration, dental practices using SOTA Cloud® –– the robust cloud-based dental imaging software which SOTA introduced last year to complement its line of state-of-the-art intraoral cameras and X-ray image sensors –– can view automatic AI detections of most conditions commonly found in dental X-rays.

“Understanding the needs of clinicians and ensuring that dentists are able to focus solely on providing the best possible patient care has always been the top priority when developing our software,” said SOTA founder and president Brian Kim. “Our partnership with Pearl speaks directly to that focus by giving practices using SOTA Cloud® push-button access to the most innovative AI technology available for streamlined patient communication and improved image-based diagnostic evaluations.”

To register for SOTA Cloud® with fully-integrated AI capabilities, visit: https://info.sotaimaging.com/sotaxpearlpartnership

To learn more about Pearl’s Second Opinion®, visit: www.hellopearl.com/products/second-opinion.

To learn more about SOTA Cloud®, visit: www.sotaimaging.com/sota-cloud

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”